| INTRODUC TI ON
Exposure to bile acids is widely recognized to be involved in the onset and progression of esophageal adenocarcinoma (EAC), [1] [2] [3] gastric stump cancer, 4, 5 and colon cancer. 6, 7 However, there remains much uncertainty regarding how bile acids influence the pathology of gastrointestinal cancers as bile acids are not mutagenic.
Persistent esophageal inflammation due to reverse flow of bile acid-containing gastric fluids is a major risk factor for EAC. The condition often precedes Barrett's esophagus, in which the stratified squamous epithelia transform into columnar epithelia. Previously, our research group has developed several models of esophageal reflux that are surgically induced by re-routing bile acid-containing duodenal contents back into the esophagus. [8] [9] [10] [11] We developed not only EACs but also esophageal squamous cell carcinomas (ESCCs) in the rat reflux models (reflux model). 8, 9, 12, 13 Our previous study also revealed that N-nitroso bile acid-mutagenic derivatives of bile acids produced in vivo under highly acidic conditions could stimulate EAC. 14, 15 However, we also observed EACs in modified Levrat models with total gastrectomy suggesting that the tumors could be induced by exposure to unmodified nonmutagenic bile acids in the absence of gastric acid. 8, 9 We selected taurocholic acid (TCA) among various bile acids to stimulate ESCC cells because of the following 5 reasons: (i) in cases with Barrett's esophagus/stricture, taurine conjugates are predominant in the esophagus; 16 (ii) increased proportions of taurine conjugates due to a high-fat diet influence Barrett's carcinogenesis in reflux models; 17 (iii) exposure to TCA promotes cell proliferation in a dose-dependent manner in an experiment using E-G junction cancer cells (OE-19); 18 (iv) chronic exposure to TCA causes tumor progression in ESCC cells; 19 and (v) acid and bile acids induce NF-κB pathway signaling in esophageal squamous cells in gastroesophageal reflux disease. [20] [21] [22] In addition, TCA significantly increased protein levels of p-NF-κB (p65) in both a time-dependent and dose-dependent manner, and TCA significantly increased nuclear translocation of NF-κB (p65) in a human cholangiocarcinoma cell line.
23
Under aerobic conditions, mammalian cells produce the energycarrying molecule, adenosine triphosphate (ATP), via the oxidative phosphorylation pathway. In 1924, however, Otto Warburg and coworkers claimed that even in the presence of adequate oxygen, cancer tissues synthesize ATP via glycolysis. 24 This phenomenon is known as the Warburg effect. 25 Other researchers have reported that cancer cells use glycolysis to synthesize a variety of critical precursor molecules, including nucleic acids, proteins, and lipids. 26 Glycolysis is an extremely inefficient system with regard to energy production, but is a boon for cancer cells in one key respect: as the pathway consumes low levels of oxygen, neoplasms can form and proliferate, even in tissues with minimal vasculature. 27 Increased activity in the major carbohydrate pathways, such as glycolysis, the pentose phosphate (PPP), and the hexosamine biosynthetic pathways (HBP), is one of the hallmarks of metabolic diseases such as cancer.
28
HBP is a sugar metabolism pathway that incorporates metabolites from major metabolic processes in the cell, such as glutamine, Acetyl-coenzyme A, glucose, and uridine, to form an amino-sugar molecule end-product (uridine diphosphate N-Acetylglucosamine,
UDP-GlcNAc).
29 UDP-GlcNAc can be conjugated into target proteins in several ways yielding N-linked and O-linked glycosylated products. [30] [31] [32] [33] The PPP is critical for the maintenance of carbon homeostasis, the provision of precursors of nucleotide and amino acid biosynthesis, the provision of reducing molecules for anabolism, and the overcoming of oxidative stress. 34 The PPP also facilitates the regeneration of the reducing agent nicotinamide adenine dinucleotide phosphate (NADPH), which, in turn, facilitates reactive oxygen species scavenging. 35 By producing the 2 key intermediates (ribose and NADPH), the PPP pathway plays a pivotal role in meeting the anabolic demands of cancer cells.
The present study investigates the biochemical pathways implicated in bile acid-induced cancer onset and progression, using metabolomics and comprehensive genetic analyses of esophageal tissues and cell lines, including EAC and ESCC tissues sampled from reflux models, 2 ESCC lines (K14D and ESCC-DR) established from primary and metastatic tumors developed in reflux models, and ESCC-DRtca stimulated with TCA to enhance malignancy.
| MATERIAL S AND ME THODS

| Animal model
All procedures complied with the ethical guidelines for animal experimentation regarding the care and use of laboratory animals at Kanazawa University of Medical Science (AP-111868), Japan.
Male Wistar rats weighing approximately 250 g were used in the present study. After fasting for 24 h, a midline laparotomy incision was made under inhalation anesthesia. Reflux of duodenal contents was induced according to previously reported procedures 8, 9 ( Figure 1 ).
bile acids are not mutagenic, chronic exposure seems to trigger G6PD overexpression and NF-κB (p65) activation, potentially inducing genetic mutations as well as facilitating carcinogenesis and cancer progression.
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| Histological findings in animal models
At postoperative wk 60, 17 reflux models were sacrificed under inhalation anesthesia. The entire length of the esophagus including the anastomosis site was excised. A specimen of the gross tumor was prepared by preserving a section of the tumor tissue at −80°C and, with it, a nonneoplastic esophageal tissue of the same specimen most proximal to the mouth as a control in the same manner. Tissues other than the cryopreserved tumor and the nonneoplastic tissues were fixed using 10% buffered formalin for use in preparing paraffin block specimens. A 2-μm specimen was prepared and histologically examined by hematoxylin and eosin (HE) staining.
| Cell lines
We were unable to examine metastatic nodules developed in these animals in the present study. Therefore, we ran similar ex- 
| Preparation for metabolome measurements of cell lines
We 
| Metabolome measurements
The homogenate of esophageal tissues and the extract of cancer cells were centrifuged at 2300 g and 4°C for 5 min. Subsequently, 
| Analyses of CE-TOFMS measurements
Peaks were extracted using automatic integration software MasterHands (Keio University, Tsuruoka, Japan) to obtain peak information including m/z, migration time for CE-TOFMS measurement (MT), and peak area. 39 Signal peaks corresponding to isotopomers, adduct ions, and other product ions of known metabolites were excluded, and the remaining peaks were annotated with puta- 
| Western blotting analysis
The samples were immersed in lysis buffer (50 mmol/L Tris-HCl, 
| Array comparative genomic hybridization (CGH) analysis
We performed a comprehensive genetic analysis of the K14D, ESCC- 
| RE SULTS
| Histological findings in animal models
Malignant tumor components were observed in 12 of the 17 models that were sacrificed. ESCC components ( 
| PCA score plot
Principal component analysis revealed characteristic patterns of expression for the metabolites from rat esophageal tissues. The PCA plot also identified 3 clusters corresponding to the mucinous adenocarcinoma, ESCC, and nonneoplastic samples ( Figure 3B ).
| HBP activation in esophageal cancer tissue
Total metabolites were extracted from mucinous adenocarcinomas Table 1 . We observed increased HBP flux in esophageal cancer tissues ( Figure 3C,D) . We particularly detected a significant increase in UDP-GlcNAc in ESCCs (Figure 3C ,D; Table 1 ).
| Immunohistochemical staining of OGT in rat tissues
We present the results of the immunohistochemical staining activity of OGT in rat tissues in Figure 4 . OGT expression considerably increased in both the ESCC ( Figure 4B ) and the mucinous adenocarcinoma ( Figure 4C ) compared with the nonneoplastic squamous epithelium located in the oral side of the tumor ( Figure 4A ).
| Microscopic findings in squamous cell carcinoma cell lines
We have illustrated the morphology of ESCC-DR, ESCC-DRtca, and K14D cells were lines in Figure 5 . K14D cells were larger than ESCC-DR and ESCC-DRtca2M, while ESCC-DRtca2M cells had podia formation.
| CE-TOFMS analysis for ESCC lines
| Two-way hierarchical clustering heatmap
Hierarchical cluster analysis revealed characteristic patterns of expres- Table 2 .
| Score of principal component analysis
Although the volumes of G6P and F6P associated with glycolysis were
TA B L E 1 Comparative analysis of metabolites in rat tissues
Compound name 
Muc vs normal (Muc)
ESCC vs normal (ESCC)
Ratio
P-value
F I G U R E 4 O-GlcNAc
| Western blotting
The various data obtained from the western blotting analyses are illustrated in Figure 7 . G6PD expression was significantly higher in 
| CGH microarray analysis of ESCC lines
Numerous F I G U R E 7 Western blot analysis of esophageal cell lines. G6PD expression was significantly higher in ESCC-DRtca2M and ESCCDRtca24h cells than in K14D and ESCC-DR cells. Both NF-κB(p65) and O-GlcNAc protein expression increased with increasing malignancy. However, no marked correlation was observed between NF-κB2 (p100/p52) and cancer progression elevated in various cancer types, including cancer of the breast, prostate, colon, lung, pancreas, and chronic lymphocytic leukemia. [45] [46] [47] [48] [49] [50] O-GlcNAcylation is a dynamic and reversible glycosylation of serine or threonine residues in a variety of nuclear and cytoplasmic proteins. 51 The addition of O-GlcNAc to proteins is catalyzed
| D ISCUSS I ON
by O-GlcNAc transferase (OGT). 52, 53 In the present study, flux to HBP was elevated in rat esophageal cancer tissues and increased UDP-GlcNAc expression was particularly apparent in ESCCs.
Furthermore, OGT expression levels increased in esophageal cancer tissues compared with in nonneoplastic squamous epithelium.
These results suggest that O-GlcNAcylation was elevated to higher levels in esophageal cancer tissues than in nonneoplastic tissues.
The western blotting analysis also confirmed that O-GlcNAc modification increased simultaneously with increase in tumor-cell malignancy in the cell line-based experiments.
NF-κB is a family of transcription factors including RelA/p65, RelB, c-Rel/Rel, p105/p50, and p100/p52. kinase. [67] [68] [69] According to previous studies, G6PD is an oncogene that is upregulated in various tumors including bladder cancer, 70 breast cancer, 71, 72 and ESCC. [73] [74] [75] The overexpression of G6PD is closely associated with the progression of gastric cancer and could be an independent predictor for the poor prognosis of gastric cancer. 76 A recent study also reported that increased G6PD expression was associated with aggressive colon cancer cases. 77 
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